Vault | Substack

Decoding Science 006: Nobel Laureates and AI, Materials for Superconducting Qubits, Bottlenecks of Artificial Research Engineers and…

Welcome to Decoding Science: every other week our writing collective highlight notable news—from the latest scientific papers to the latest funding…

Published on Decoding Science • Oct 21, 2025

Decoding Bio Snapshot 2023

a look into the next generation of bio companies

Published on Decoding Bio • Jul 6, 2023

Enveda Biosciences: Behind the Scenes

What makes Enveda achieve so much, so quickly?

Published on Hummingbird Ventures • May 16, 2023

Is Your Discovery Platform Validated?

Pablo Lubroth is an investor at Hummingbird Ventures, a global early stage fund, where he covers bio + health.

Jun 3, 2022 • Pablo Lubroth

Defensibility Through Execution: Building the Next Generation of Bio Platforms

Biologists and engineers can now start companies with little more than an idea. So how do we develop a durable defensibility?

Jun 3, 2022 • Xinchen Wang and Pablo Lubroth

Vault

About Archive Recommendations Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts